Wonder if this will force Onyx to make a move seeing as PAT-SM6 worked well in combination therapy.
If they have no signed licensing deal takeda could come in and sign one before their competitors do.
Also Takeda ventures are on our top 20 list. Not a big holding but I am pretty sure they have been holding PAB since they listed.
http://www.takedaventures.com/
Lots to think about.
Wonder if this will force Onyx to make a move seeing as PAT-SM6...
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $3.117K | 1.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 44343144 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10764841 | 13 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |